Background

The most consequential single document in modern MLB drug-policy history. The Mitchell Report transformed the post-2005-Congressional-hearings landscape from public-pressure-driven incrementalism to comprehensive structural reform. The 2008 JDA amendments (later embedded in the 2007-2011 CBA cycle's continuation) implemented most of Mitchell's recommendations. The Report's named-player list also drove the December 18, 2007 House Oversight Committee hearings (with Mitchell, Selig, Fehr) and the February 13, 2008 hearing at which Roger Clemens and Brian McNamee testified — the latter producing federal perjury indictments against Clemens (eventually acquitted at his second trial in 2012). George Mitchell had previously authored the 2000 Blue Ribbon Report (also in this archive). The Report's procedural choices have been criticized: notably the MLBPA's refusal to cooperate left the witness base limited to non-player sources, and the named-player list was criticized for inconsistent evidentiary standards. Brian McNamee's basement evidence (the syringes and gauze pads with Clemens's purported DNA) became the central evidence in the Clemens perjury trial. The single most important document for any analysis of how the steroid era was handled. Bonds, Clemens, Tejada — the case files. Selig's response. The MLBPA's pushback. The JDA amendments that followed. The Hall of Fame voting debates that the named-player list directly produced. Mitchell, Hocking and Salem (Mitchell's firm at the time, later DLA Piper) was paid $19.6 million by MLB for the investigation.

Key provisions

• Author: Hon. George J. Mitchell, DLA Piper US LLP (former U.S. Senate Majority Leader, D-ME). Same Mitchell who authored the 2000 Blue Ribbon Report on Baseball Economics.
• Commission: Named special investigator by Commissioner Selig on March 30, 2006. 21-month investigation.
• Length: 409 pages including extensive appendices, exhibits, and the named-player list.
• Named players (89 total): Most prominently Barry Bonds, Roger Clemens, Andy Pettitte, Miguel Tejada, Eric Gagne, Lenny Dykstra, Mo Vaughn, Wilson Alvarez, Mike Stanton, Paul LoDuca, Kevin Brown, Gary Sheffield, Jason Giambi, Rafael Palmeiro, Sammy Sosa (others surfaced after the report's release). Full named-player list with documentary evidence is contained in the Report's body sections and appendices.
• Key sources: Kirk Radomski (former Mets clubhouse attendant, cooperating witness following 2007 federal plea agreement) and Brian McNamee (Roger Clemens's former trainer, also cooperating witness). Documentary evidence included financial records, FedEx packaging materials, handwritten notes.
• Substantive conclusion: 'The use of steroids in Major League Baseball was widespread. The response to the use was slow to develop and initially ineffective. For decades, MLB players responded to a culture of acceptance.'
• Key recommendations (most adopted in the 2008 JDA amendments): independent administration of the drug program (Independent Program Administrator); random off-season testing; HGH research and eventual blood testing (adopted 2013); educational programs; investigator access; transparency reforms.
• Response from MLB: Commissioner Selig accepted the Report's recommendations and committed to implementing them via collective bargaining.
• Response from MLBPA: Executive Director Donald Fehr criticized aspects of the Report's methodology (particularly the reliance on Radomski and McNamee) but committed to negotiating reforms.

Notable provisions

[Body text not yet transcribed — 409-page report. Future detailed-review pass should extract: (1) the 'widespread use' conclusion from the Executive Summary; (2) Radomski sourcing methodology; (3) named-player evidentiary thresholds; (4) recommendations 1-20; (5) Bonds, Clemens, Tejada specific findings.]— Mitchell Report (Dec. 13, 2007)

Further context

The Mitchell Report (December 13, 2007)

The foundational document of modern MLB drug-policy history. 409 pages. Phase 1 wantlist hit cleared.

Overview

Former Senate Majority Leader George Mitchell — the same Mitchell who wrote the 2000 Blue Ribbon Report (also in archive) — was named MLB's special investigator by Commissioner Selig in March 2006. 21 months later, the Report identified 89 current and former MLB players as alleged users of performance-enhancing substances, drawn primarily from documentary evidence provided by Kirk Radomski (former Mets clubhouse employee) and Brian McNamee (Roger Clemens's former trainer).

The substantive conclusion was foundational: "The use of steroids in Major League Baseball was widespread. The response to the use was slow to develop and initially ineffective. For decades, MLB players responded to a culture of acceptance."

Why this is foundational

Every subsequent MLB drug-policy framework descends from the Mitchell Report. The 2008 JDA amendments (later carried into the 2022-26 cycle's JDPTP in this archive) adopted Mitchell's structural recommendations: Independent Program Administrator, random off-season testing, HGH testing (eventually 2013), educational programs, transparency reforms.

The Report also produced the Hall of Fame voting debates over steroid-era players that have shaped post-2010 cooperstown coverage — Bonds, Clemens, Sosa, Tejada, McGwire, et al. all sit on top of this Report's evidentiary record.

Related documents

• 2000-07-17_report_blue-ribbon-panel-on-baseball-economics.md — Mitchell's earlier report.
• 2008_hearing_house-mitchell-report-followup.md — the December 2007 / February 2008 follow-up hearings.
• 1991-06-07_memo_vincent-drug-policy-program.md — the pre-Mitchell unilateral commissioner framework.
• 2022-01-01_policy_joint-drug-prevention-treatment-program.md — the current JDPTP, descended directly from the post-Mitchell 2008 amendments.

Why this matters

This is the single most important document for any analysis of how the steroid era was handled. Bonds, Clemens, Tejada — the case files. Selig's response. The MLBPA's pushback (Donald Fehr raised specific methodology criticisms). The JDA amendments that followed. The Hall of Fame voting debates. Brian McNamee's basement evidence and the Clemens perjury trials.

Verification status

needs_review. Single source (MLB's official mlbstatic.com). Detailed content review of the 409-page report pending.

Related documents

Related documents

Blue Ribbon Report on Baseball Economics (2000), 2008 House Oversight Mitchell Report Hearings, 1991 Vincent Drug Memo, 2002-2006 MLB Basic Agreement, Joint Drug Program (2022–2026)

Source provenance

• Primary source